Ardelyx Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ardelyx Inc (ARDX)
Ardelyx Inc stock price live, this page displays NASDAQ ARDX stock exchange data. View the ARDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ardelyx Inc real time stock price chart below.
What Is the Ardelyx Inc Stock Price Today?
The Ardelyx Inc stock price today is 4.445.
What Is the Stock Symbol for Ardelyx Inc?
The stock symbol for Ardelyx Inc is ""ARDX.""
What Stock Exchange Does Ardelyx Inc Trade On?
Ardelyx Inc is listed and trades on the NASDAQ stock exchange.
Is Ardelyx Inc a Good Stock to Buy?
Determining whether Ardelyx Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARDX quote. (ISIN: US0396971071)
What Is the Ardelyx Inc Stock Price Today?
The Ardelyx Inc stock price today is 4.445.
What Is the Stock Symbol for Ardelyx Inc?
The stock symbol for Ardelyx Inc is ""ARDX.""
What Stock Exchange Does Ardelyx Inc Trade On?
Ardelyx Inc is listed and trades on the NASDAQ stock exchange.
Is Ardelyx Inc a Good Stock to Buy?
Determining whether Ardelyx Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARDX quote. (ISIN: US0396971071)
4.445
+0.115(+2.66%)
Real-time Data·
Fair Value
An estimate of a Ardelyx Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.240
4.450
52 wk Range
3.210
7.180
ARDX Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
ARDX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Ardelyx Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.2404.450
52 wk Range
3.2107.180
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ARDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ardelyx Inc's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
10.818
Upside
+143.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
- Ardelyx Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 8K Ardelyx Inc For: 3 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Ardelyx Inc Company Profile
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Ardelyx Inc Earnings Call Summary for Q1/2025
- Q1 2025: Net loss of $0.17/share, missing $0.11 forecast; revenue $74.1M, below $78.09M expected; stock fell 17.92% after-hours
- Revenue up 61% YoY; IBSRELA sales $44.4M (+57% YoY), XPOVIO $23.4M (+55% YoY); company maintains $214M cash and equivalents
- 2025 guidance: IBSRELA net sales projected $240-250M; XPOVIO peak sales target $750M; exploring corporate development opportunities
- Challenges: Medicare Part D changes impact on XPOVIO; competition in IBS-C and hyperphosphatemia markets; potential litigation risks
- CEO Mike Robb: 'Building a great company, focused on delivering shareholder value'; strong financial health with 4.58 current ratio
Last Updated: 01/05/2025, 22:22
Read Full TranscriptCompare ARDX to Peers and Sector
Metrics to compare | ARDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −19.5x | −1.6x | −0.5x | |
PEG Ratio | −0.87 | 0.00 | 0.00 | |
Price/Book | 7.2x | 2.3x | 2.6x | |
Price / LTM Sales | 2.9x | 5.5x | 3.3x | |
Upside (Analyst Target) | 130.9% | 173.2% | 45.1% | |
Fair Value Upside | Unlock | 22.3% | 7.4% | Unlock |
Analyst Ratings
11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 10.818
(+143.38% Upside)
Earnings
Latest Release
May 01, 2025
EPS / Forecast
-0.17 / -0.11
Revenue / Forecast
74.11M / 78.09M
People Also Watch
FAQ
What Stock Exchange Does Ardelyx Inc Trade On?
Ardelyx Inc is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Ardelyx Inc?
The stock symbol for Ardelyx Inc is "ARDX."
What Is the Ardelyx Inc Market Cap?
As of today, Ardelyx Inc market cap is 1.06B.
What Is Ardelyx Inc's Earnings Per Share (TTM)?
The Ardelyx Inc EPS (TTM) is -0.23.
When Is the Next Ardelyx Inc Earnings Date?
Ardelyx Inc will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is ARDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Ardelyx Inc Stock Split?
Ardelyx Inc has split 0 times.
How Many Employees Does Ardelyx Inc Have?
Ardelyx Inc has 395 employees.
What is the current trading status of Ardelyx Inc (ARDX)?
As of 04 Aug 2025, Ardelyx Inc (ARDX) is trading at a price of 4.45, with a previous close of 4.33. The stock has fluctuated within a day range of 4.24 to 4.45, while its 52-week range spans from 3.21 to 7.18.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.